In addition, the correlation between TGF-β and Tregs was also confirmed in hepatic carcinoma patients and the expression of both TGF-β and IL-10 was shown to be associated with hepatic carcinoma progression [16], as well as PDAC [33]. Here, TGFB1 is linked to hepatocellular carcinoma.